St. Laurent Institute Revenue and Competitors

The St. Laurent Institute focuses on novel Systems Biology and Genomics approaches to understand the molecular mechanisms of chronic disease. We use high throughput technologies such as single molecule transcriptome and Epigenome sequencing to decipher the intricate molecular pathways of these diseases that threaten the lives and health of our aging populations. SLI was founded in 2005 as a non-profit medical research institute by Georges St. Laurent, Jr., an original Board member of the Celera Human Genome Project, and Georges St. Laurent, III, an accomplished molecular biologist and neuroscientist. SLI’s global research activities include projects in Germany, Japan, India, Russia, the Amazonian region of Colombia, Brazil, The People’s Republic of China, and the United States. SLI maintains research collaborations with academic investigators at institutions around the U.S.A and the world. Research interests include the molecular mechanisms of physiological information flow through molecular networks during stress and disease. We spearhead research collaborations, analysis, conference strategies, grant topic exploration, management, bio-informatics support, application writing, publications and poster development, and generalized orchestration in support of RNA based research as we partially fund scientific and bio-informatician teams working on collaborative research resulting in expanded studies in support of improved global healthcare including SeqLL, Inc. and True Bearing Diagnostics, Heel, OHSU and others.